HC Wainwright set a $4.00 target price on Aquabounty Technologies (NASDAQ:AQB) in a report released on Thursday, March 28th, Stock Target Advisor reports. The brokerage currently has a buy rating on the stock.
A number of other analysts have also recently commented on the stock. National Securities lowered their target price on shares of Aquabounty Technologies from $6.50 to $5.50 and set a buy rating for the company in a research note on Wednesday, March 20th. Zacks Investment Research cut shares of Aquabounty Technologies from a hold rating to a sell rating in a research note on Wednesday, March 20th. Finally, ValuEngine cut shares of Aquabounty Technologies from a buy rating to a hold rating in a research note on Friday, December 21st.
Shares of Aquabounty Technologies stock traded up $0.05 on Thursday, reaching $2.26. The stock had a trading volume of 173,008 shares, compared to its average volume of 415,414. The company has a quick ratio of 3.75, a current ratio of 3.83 and a debt-to-equity ratio of 0.15. Aquabounty Technologies has a 1 year low of $1.51 and a 1 year high of $5.45. The company has a market cap of $48.81 million, a P/E ratio of -2.40 and a beta of 0.41.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. PFG Advisors acquired a new position in shares of Aquabounty Technologies in the 4th quarter valued at $33,000. Actinver Wealth Management Inc. acquired a new position in shares of Aquabounty Technologies in the 4th quarter valued at $69,000. Finally, Third Security LLC lifted its stake in shares of Aquabounty Technologies by 20.4% in the 4th quarter. Third Security LLC now owns 9,076,753 shares of the company’s stock valued at $18,607,000 after purchasing an additional 1,538,461 shares during the period. Institutional investors and hedge funds own 54.30% of the company’s stock.
About Aquabounty Technologies
AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.
Further Reading: Fiduciary
Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.